首页 / 院系成果 / 成果详情页

RECORD-4 multicenter phase 2 trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Pooled anti-VEGF cohort subanalysis  会议论文  

  • 编号:
    79b9440b-1b06-4ca5-8981-3bae02ffb4a9
  • 作者:
    Alekseev, B.; Yang, L.; Alyasova, A.; Ye, D.; Karpenko, A.; Li, H.; Xie, L.; Kurteva, G.; Kowalyszyn, R.; Karyakin, O.; Neron, Y.; Cosgriff, T.; Collins, L.; Brechenmacher, T.; Lin, J.; Morgan, L.; Motzer, R.
  • 作者单位:
    [Alekseev, B.] Moscow Hertzen Oncol Inst, Dept Oncol, Moscow, Russia; [Yang, L.] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Oncol, Beijing 100730, Peoples R China; [Alyasova, A.] Prevoljskiy Reg Med Ctr, Dept Oncol, Novgorod, Russia; [Ye, D.] Fudan Univ, Dept Oncol, Shanghai Canc Ctr, Shanghai 200433, Peoples R China; [Karpenko, A.] Leningrad Reg Oncol Dispensary, Dept Oncol, St Petersburg, Russia; [Li, H.] Beijing Union Med Coll Hosp, Dept Oncol, Beijing, Peoples R China; [Xie, L.] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Oncol, Hangzhou, Zhejiang, Peoples R China; [Kurteva, G.] Ctr Oncol, Dept Med Oncol, Sofia, Bulgaria; [Kowalyszyn, R.] Ctr Invest Clin Clin Viedma, Dept Oncol, Viedma, Rio Negro, Argentina; [Karyakin, O.] Med Radiol Res Ctr, Dept Oncol, Obninsk, Russia; [Neron, Y.] Ctr Pesquisas Oncol CEPON, Dept Oncol, Florianopolis, SC, Brazil; [Cosgriff, T.] Crescent City Res Consortium, Dept Oncol, Marrero, LA USA; [Collins, L.; Lin, J.; Morgan, L.] Novartis Oncol, Dept Oncol, E Hanover, NJ USA; [Brechenmacher, T.] Novartis Pharma SAS, Dept Oncol, Rueil Malmaison, France; [Motzer, R.] Mem Sloan Kettering Canc Ctr, Dept Oncol, New York, NY 10021 USA
  • 会议名称:
    EUROPEAN JOURNAL OF CANCER
  • 会议时间:
  • 出版信息:
    2015 年 51 卷 (S518 - S519)
浏览次数:1 下载次数:0
浏览次数:1
下载次数:0
打印次数:0
浏览器支持: Google Chrome   火狐   360浏览器极速模式(8.0+极速模式) 
返回顶部